SkinbiotherapeuticsSBTX 
$0.13-0.94%24h
-0.94%24h
Global rank
Market cap$21.67M
Change 7d-14.95%
YTD Performance-30.98%
SP500 benchmarkUnderperform
P/E-7.65
P/S131.28
Revenue$165.04K
Earnings-$3.54M
Dividend yield-
Main Sector
Healthcare
Category
EPS for Skinbiotherapeutics (SBTX)
Skinbiotherapeutics has an EPS of $-0.0172. In 2022, the company made an earnings per share (EPS) of $-0.0178. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for SBTX
-
Value:-
EPS history for Skinbiotherapeutics from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$0.0172 | -3.37% |
| 2022 | -$0.0178 | 81.63% |
| 2021 | -$0.0098 | -16.24% |
| 2020 | -$0.0117 | - |
View the highest EPS stocks
